Press Releases

NEW YORK, Oct. 10, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, announces that the Company's common stock will begin trading on The Nasdaq Capital Market beginning at 9:30 a.m. ET today,

JERSEY CITY, N.J., Oct. 10, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, has received notification from the State of New Jersey of its available unused net operating losses (NOLs) and

RIDGEFIELD, Conn., Oct. 10, 2019 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Ofev® (nintedanib), which is currently under FDA review for the treatment of people with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. Regulatory applicat

PARSIPPANY, N.J., Oct. 10, 2019 /PRNewswire/ -- Point of Care Network (POCN) is the largest network of Nurse Practitioners (NPs) and Physician Assistants (PAs) in America and started America's Top PAs three years ago with the goal of recognizing and celebrating influential and impactful PAs practicing today. While physicians have been able to nominate their peers

PENNINGTON, N.J., Oct. 10, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (Nasdaq:ONCS), a late-stage intratumoral cancer immunotherapy company, today announced it entered into a strategic transaction with Grand Decade Developments Limited (Grand Decade), a direct, wholly-owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited (CGP) (H

ENGLEWOOD, Colo., Oct. 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled "Evaluating the Efficacy and Safety of AmpionTM to treat Adults with Pain Due to Severe Osteoarthritis of the Knee," today announced update

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developmen

CHICAGO and TAMPA, Fla., Oct. 10, 2019 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian), a WellCare Health Plans, Inc. (NYSE: WCG) company, rated among the top Medicaid plans in the state, according to the National Committee for Quality Assurance (NCQA) Medicaid Health Insurance Plan Ratin

DETROIT and TAMPA, Fla., Oct. 10, 2019 /PRNewswire/ -- Meridian Health Plan of Michigan, Inc. (Meridian), a WellCare Health Plans, Inc. (NYSE: WCG) company, received an overall score of 4 out of 5 in the National Committee for Quality Assurance (NCQA) Medicaid Health Insurance Plan Ratings 2019-2

LOUISVILLE, Ky. and TAMPA, Fla., Oct. 10, 2019 /PRNewswire/ -- WellCare of Kentucky, Inc., a WellCare Health Plans, Inc. (NYSE: WCG) company and the commonwealth's largest Medicaid provider, earned the highest rating in consumer satisfaction in Kentucky by the nation's top